The goal of replenishing the cardiomyocyte (CM) population using regenerative therapies following myocardial infarction (MI) is hampered by the limited regeneration capacity of adult CMs, partially due to their withdrawal from the cell cycle. Here, we show that microRNA-128 (miR-128) is upregulated in CMs during the postnatal switch from proliferation to terminal differentiation. In neonatal mice, cardiac-specific overexpression of miR-128 impairs CM proliferation and cardiac function, while miR-128 deletion extends proliferation of postnatal CMs by enhancing expression of the chromatin modifier SUZ12, which suppresses p27 (cyclin-dependent kinase inhibitor) expression and activates the positive cell cycle regulators Cyclin E and CDK2. Furthermore, deletion of miR-128 promotes cell cycle re-entry of adult CMs, thereby reducing the levels of fibrosis, and attenuating cardiac dysfunction in response to MI. These results suggest that miR-128 serves as a critical regulator of endogenous CM proliferation, and might be a novel therapeutic target for heart repair.
Tumor
hypoxia is the Achilles heel of oxygen-dependent photodynamic
therapy (PDT), and tremendous challenges are confronted to reverse
the tumor hypoxia. In this work, an oxidative phosphorylation inhibitor
of atovaquone (ATO) and a photosensitizer of chlorine e6 (Ce6)-based
self-delivery nanomedicine (designated as ACSN) were prepared via
π–π stacking and hydrophobic interaction for O2-economized PDT against hypoxic tumors. Specifically, carrier-free
ACSN exhibited an extremely high drug loading rate and avoided the
excipient-induced systemic toxicity. Moreover, ACSN not only dramatically
improved the solubility and stability of ATO and Ce6 but also enhanced
the cellular internalization and intratumoral permeability. Abundant
investigations confirmed that ACSN effectively suppressed the oxygen
consumption to reverse the tumor hypoxia by inhibiting mitochondrial
respiration. Benefiting from the synergistic mechanism, an enhanced
PDT effect of ACSN was observed on the inhibition of tumor growth.
This self-delivery system for oxygen-economized PDT might be a potential
appealing clinical strategy for tumor eradication.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.